1. Decoy oligodeoxynucleotide technology: an emerging paradigm for breast cancer treatment
   Maryam Mahjoubin Tehran et al, 2020, Drug Discovery Today CrossRef
2. Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
   Sepideh Mirzaei et al, 2023, Pathology - Research and Practice CrossRef
3. Cancer stem cells and strategies for targeted drug delivery
   Jin Cao et al, 2021, Drug Delivery and Translational Research CrossRef
4. Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer
   Seyed Mohammad Ali Hosseini Rad et al, 2015, Tumor Biology CrossRef
5. Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R
   Kai Shi et al, 2018, Journal of Controlled Release CrossRef
6. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer
   Shuang Li et al, 2015, Cancer Biology & Therapy CrossRef
7. Weiqi Decoction Attenuated Chronic Atrophic Gastritis with Precancerous Lesion through Regulating Microcirculation Disturbance and HIF-1α Signaling Pathway
   Jing Yin et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Cancer stem cells, lymphangiogenesis, and lymphatic metastasis
   Shuang Li et al, 2015, Cancer Letters CrossRef